1. Home
  2. MOGO vs CGTX Comparison

MOGO vs CGTX Comparison

Compare MOGO & CGTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • MOGO
  • CGTX
  • Stock Information
  • Founded
  • MOGO 2003
  • CGTX 2007
  • Country
  • MOGO Canada
  • CGTX United States
  • Employees
  • MOGO N/A
  • CGTX N/A
  • Industry
  • MOGO
  • CGTX Biotechnology: Pharmaceutical Preparations
  • Sector
  • MOGO
  • CGTX Health Care
  • Exchange
  • MOGO Nasdaq
  • CGTX Nasdaq
  • Market Cap
  • MOGO 32.5M
  • CGTX 30.0M
  • IPO Year
  • MOGO N/A
  • CGTX 2021
  • Fundamental
  • Price
  • MOGO $1.15
  • CGTX $0.58
  • Analyst Decision
  • MOGO Strong Buy
  • CGTX Strong Buy
  • Analyst Count
  • MOGO 1
  • CGTX 6
  • Target Price
  • MOGO $6.00
  • CGTX $8.30
  • AVG Volume (30 Days)
  • MOGO 56.7K
  • CGTX 809.4K
  • Earning Date
  • MOGO 03-19-2025
  • CGTX 03-25-2025
  • Dividend Yield
  • MOGO N/A
  • CGTX N/A
  • EPS Growth
  • MOGO N/A
  • CGTX N/A
  • EPS
  • MOGO N/A
  • CGTX N/A
  • Revenue
  • MOGO $30,995,226.00
  • CGTX N/A
  • Revenue This Year
  • MOGO N/A
  • CGTX N/A
  • Revenue Next Year
  • MOGO $3.73
  • CGTX N/A
  • P/E Ratio
  • MOGO N/A
  • CGTX N/A
  • Revenue Growth
  • MOGO N/A
  • CGTX N/A
  • 52 Week Low
  • MOGO $0.94
  • CGTX $0.34
  • 52 Week High
  • MOGO $2.25
  • CGTX $2.95
  • Technical
  • Relative Strength Index (RSI)
  • MOGO 36.67
  • CGTX 40.43
  • Support Level
  • MOGO $1.14
  • CGTX $0.57
  • Resistance Level
  • MOGO $1.22
  • CGTX $0.65
  • Average True Range (ATR)
  • MOGO 0.07
  • CGTX 0.05
  • MACD
  • MOGO -0.01
  • CGTX -0.01
  • Stochastic Oscillator
  • MOGO 4.88
  • CGTX 9.46

About MOGO Mogo Inc.

Mogo Inc is a Canadian-based financial technology company. It offers a finance application to consumers with solutions that help them to control their financial health. At Mogo, users can sign up for a free account and get access to products and solutions that help users to monitor their credit score, protect themselves from identity fraud, control their spending, and borrow responsibly. Company offers digital loans and mortgages and also offer a digital payments platform that powers next-generation card programs for both established global corporations and innovative fintech companies in Europe and Canada.

About CGTX Cognition Therapeutics Inc.

Cognition Therapeutics Inc is a clinical-stage biopharmaceutical company engaged in the discovery and development of, small-molecule therapeutics targeting age-related degenerative diseases and disorders of the central nervous system and retina. Its product candidate CT1812, is an orally delivered, small-molecule antagonist designed to penetrate the blood-brain barrier and bind selectively to the S2R complex.

Share on Social Networks: